Breast Cancer Clinical Trials

Showing 2881-2900 of 4,817 trials

Ten Fraction Adjuvant Hypofractionated Radiotherapy in Node Positive Breast Cancer

NCT04792346

Post-operative loco-regional (LR) hypofractionated radiotherapy (Hypo-RT) is an attractive approach in locally advanced breast cancer (LABC).

Breast Cancer

Regina Elena Cancer Institute61 participantsStarted Jan 2015

Rome, Italy

COMPLETEDPhase 2

Effect of Bevacizumab in Metastatic Triple Negative Breast Cancer

NCT03577743

Evaluating efficacy and safety of bevacizumab when combined with chemotherapy (carboplatin and Paclitaxel ) in treatment of patient with metastatic triple negative breast cancer

Metastatic Triple Negative Breast CancerSafety IssuesEfficacy

Assiut University54 participantsStarted Jul 2018

Asyut, Assuit, Egypt

COMPLETEDNA

Provider Training in Increasing Patient Tobacco Cessation Counseling and Referrals for Patients With Cancer Undergoing Radiation Therapy

NCT03135782

This pilot clinical trial studies how well provider training works in increasing patient tobacco cessation counseling and referrals for patients with cancer undergoing radiation therapy. Health care provider training in motivational interviewing techniques and utilizing tobacco cessation resources may help doctors understand how health care providers can effectively increase their confidence in talking to patients about tobacco cessation counseling.

Breast CarcinomaCaregiverHead and Neck Carcinoma+3 more

OHSU Knight Cancer Institute2 participantsStarted Aug 2017

Portland, Oregon, United States

Ten Fraction Adjuvant Hypofractionated Radiotherapy in Node Positive Breast Cancer

Effect of Bevacizumab in Metastatic Triple Negative Breast Cancer

Provider Training in Increasing Patient Tobacco Cessation Counseling and Referrals for Patients With Cancer Undergoing Radiation Therapy

Related Searches

Effects of Manual Therapy on Chronic Pain and Functionality of Breast Cancer Survivors

Liposomal Doxorubicin Compared With Observation or Cyclophosphamide and Methotrexate in Treating Older Women Who Have Undergone Surgery for Breast Cancer

Abiraterone Acetate in Molecular Apocrine Breast Cancer

Niraparib Combined With Anlotinib in Homologous Recombination Repair (HRR) Gene-mutated Advanced Solid Tumors

SEroma Reduction pOst MAstectomy "SEROMA Study"

Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast Cancer

Breath Test to Predict Breast Cancer and Outcome of Mammography

Talazoparib Maintenance Therapy in Triple-negative Breast Cancer

Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast Cancer

Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant Treatment

Clinical Outcome and Toxicity Data in Patients With Advanced Breast Cancer Treated With CDK Inhibitors Combined With Endocrine Therapy

Influence of Co-Vid 19 Pandemic on Screening Mammography Single Institution

A Study of HX008 for the Treatment of Patients With Metastatic Triple Negative Breast Cancer

Registry Trial to Evaluate the Clinical Utilization of Targeted Axillary Dissection (TAD)

Prevention and Treatment of Pyrrolitinib-associated Diarrhea

Delphinus SoftVue™ ROC Reader Study (DMT SV RRS3)

Eribulin in mTNBC Patients